Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers
Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K.
Voprosy Onkologii 59(2): 5-11
2013
ISSN/ISBN: 0507-3758 PMID: 23814843 Document Number: 664252
Document emailed within 1 workday
Related Documents
Carlson, K.; Chung, A.; Mirocha, J.; Donovan, C.; Estrada, S.; Siegel, E.; Giuliano, A.; Amersi, F. 2018: Menopausal Status and Outcomes of BRCA Mutation Carriers with Breast Cancer American Surgeon 84(10): 1584-1588Hirsh-Yechezkel, G.; Chetrit, A.; Lubin, F.; Friedman, E.; Peretz, T.; Gershoni, R.; Rizel, S.; Struewing, J.P.; Modan, B. 2003: Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel Gynecologic Oncology 89(3): 494-498
Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H. 2001: Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations Strahlentherapie und Onkologie 177(7): 325-329
Grann, V. 1997: Risk of breast cancer in carriers of BRCA gene mutations New England Journal of Medicine 337(11): 788
Levavi, H.; Sabah, G. 2003: BRCA susceptibility genes--a review of current conservative management of BRCA mutation carriers European Journal of Gynaecological Oncology 24(6): 463-466
Biglia, N.; D'Alonzo, M.; Sgro, L.G.; Tomasi Cont, N.; Bounous, V.; Robba, E. 2016: Breast cancer treatment in mutation carriers: surgical treatment Minerva Ginecologica 68(5): 548-556
Van der Linden, M.H. 2000: Psychosocial counseling after diagnosis for non-carriers of hereditary breast cancer or ovarian cancer; is it needed? Nederlands Tijdschrift Voor Geneeskunde 144(50): 2381-2384
Stratton, J.F.; Buckley, C.H.; Lowe, D.; Ponder, B.A. 1999: Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group Journal of the National Cancer Institute 91(7): 626-628
Triantafyllidou, O.; Vlachos, I.S.; Apostolou, P.; Konstantopoulou, I.; Grivas, A.; Panopoulos, C.; Dimitrakakis, C.; Kassanos, D.; Loghis, C.; Bramis, I.; Vlahos, N.; Yannoukakos, D.; Fostira, F. 2015: Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece Journal of BUON: Official Journal of the Balkan Union of Oncology 20(4): 978-984
Bershteĭn, L.M.; Pozharisskiĭ, K.M.; Maksimova, N.A.; Kovalevskiĭ, A.I.; Imianitov, E.N. 2009: An immunohistochemical study of aromatase, estrogen 4-hydroxylase and fatty acid synthetase in breast cancer tissues from BRCA1 mutation carriers Voprosy Onkologii 55(1): 29-32
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Antoniou, A.C.; Rookus, M.; Andrieu, N.; Brohet, R.; Chang-Claude, J.; Peock, S.; Cook, M.; Evans, D.Gareth.; Eeles, R.; Nogues, C.; Faivre, L.; Gesta, P.; van Leeuwen, F.E.; Ausems, M.G.E.M.; Osorio, A.; Caldes, T.; Simard, J.; Lubinski, J.; Gerdes, A-Marie.; Olah, E.; Fürhauser, C.; Olsson, H.; Arver, B.; Radice, P.; Easton, D.F.; Goldgar, D.E. 2009: Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 18(2): 601-610
Menkiszak, J.; Chudecka-Głaz, A.; Gronwald, J.; Bedner, R.; Cymbaluk-Płoska, A.; Wezowska, Młgorzata.; Zielińska, D.; Rzepka-Górska, I. 2013: Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries Ginekologia Polska 84(9): 758-764
Narod, S.A.; Sun, P.; Risch, H.A. 2001: Ovarian cancer, oral contraceptives, and BRCA mutations New England Journal of Medicine 345(23): 1706-1707
Atoum, M.F.; Al-Kayed, S.A. 2004: Mutation analysis of the breast cancer gene BRCA1 among breast cancer Jordanian females Saudi Medical Journal 25(1): 60-63
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Gil, F. 1996: Hereditary breast cancer risk: factors associated with the decision to undergo BRCA 1 testing European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 5(6): 488-490
Friedenson, B.; Friedenson, H. 2002: Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives Medgenmed: Medscape General Medicine 4(3): 3
Giles, K.; Flynn, P.J.; Dalton, R.; Zera, R. 1993: National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial Minnesota Medicine 76(12): 25-27
Kuhl, C.K. 2002: High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene) Journal of Experimental and Clinical Cancer Research: Cr 21(3 Suppl): 103-106